The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
about
Modulation of DNA damage and repair pathways by human tumour virusesThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseGenetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationThe Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.EBNA1 and LMP1 variants in multiple sclerosis cases and controls.Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.Epstein-Barr virus genetic variants are associated with multiple sclerosis.Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancerVariations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.Epstein-Barr virus-positive T/NK-cell lymphoproliferative disordersIdentification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.High prevalence of the EBER variant EB-8m in endemic nasopharyngeal carcinomas.Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern ChinaDistinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphismsSequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas.A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma.Meeting the challenge of hematologic malignancies in sub-Saharan AfricaCharacterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma ProgressionEpstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinomaAssociation of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysisIdentification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing TechnologyIdentification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western KenyaPre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy.Analysis of the Variability of Epstein-Barr Virus Genes in Infectious Mononucleosis: Investigation of the Potential Correlation with Biochemical Parameters of Hepatic Involvement.The biological properties of different Epstein-Barr virus strains explain their association with various types of cancersClonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.Epstein-Barr virus strains and variations: Geographic or disease-specific variants?Functional analysis and molecular characterization of spontaneously outgrown human lymphoblastoid cell lines.Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).
P2860
Q26825783-1B80798A-A85D-484D-B673-6071954C80DEQ26998401-43CA2D52-732D-4E31-8B1A-348D5DEF06AFQ28731826-44351D5D-05A1-4455-8BFB-2FEFF3E52C92Q30278553-5436C3FF-3171-4FA8-A927-39AECB3C5610Q33583294-E46C80FE-41F6-44FF-A2A0-9EF1EA66A980Q33842180-5B8254E6-30F5-4D78-919B-5B047C3F08EBQ33925373-6F1C645C-CD2A-4906-8E04-2CA7C87D7A5FQ34249710-1C7017D0-70AD-474B-9E84-4D36C1B3DFB9Q34271121-8B7B2831-73B5-422F-8FF5-43BEEE4623F0Q34410536-3367D1B9-525E-43AA-A8B0-08D0F64F8532Q34465744-735CE1C2-8E86-42C6-A5D2-1199DBAFF258Q34489193-799250E5-AE2E-44C1-9758-AC0BB1693E1DQ34493991-F728DBF9-8843-4FAE-BE22-AC791AFC722BQ35040638-8C1EF093-ACF5-4F37-92A1-580EE8487E6BQ35115637-7365B1A5-D5C4-4EF9-B08D-8DC86A30700FQ35586536-B69829FB-ECC3-46C2-8DD6-8A6351C648EFQ35620244-A7EA75D9-C5A8-4946-8C27-284B773EA39AQ35665981-0903ED06-E60C-4712-9966-F9ADF77EE4E1Q35717137-095664C0-7D02-45E6-A95E-74DA37B50959Q35804593-D5258AD6-8A68-4F00-BF99-524D62987131Q35807158-6C79EE99-4864-4AC9-96BF-9ECB9A3639E5Q35854314-5A432A92-ED45-4070-B7B4-F3A9D01FF0B9Q35857642-88DC224F-1F2B-42E8-9093-D5CA6D8D5FF4Q35865085-A4262EF7-46C4-45BF-867B-4CBD1C96717FQ35987387-A72AD3A5-28A9-4D03-869E-CDF33BF30825Q36305650-EA6B127E-57A7-4C61-A09A-4BC2B23502E1Q36318425-9AFA0B8E-22D0-4DCF-A9F1-93062ECB062FQ36424931-5CC75327-0474-495E-9F79-45CC44E2B93FQ36524063-E77775F6-1E88-442A-BB89-178BA0999F67Q36910371-6494A655-30C5-4543-89C5-9EEBBABA9BF4Q37356629-5A27B578-1273-44E0-8CF7-DB8CDFA8EC8EQ37582160-A60B3A33-8D60-483A-89BC-76D5EB68C3F1Q37694965-A3F59BE5-FD50-4553-B462-77826BCDFD8EQ37705818-ED2D9E7C-108F-4A92-B244-BD7D5816B6D2Q38779524-64B52A21-5250-460D-86BD-310F455BF6DBQ38855080-8D6EB694-30F5-4965-8AD0-D69380D7D5C0Q38901360-D560E102-F57D-4768-A95B-BA6BC1D41AB7Q38974233-06586E22-571A-485B-9395-4E1C8A0DA478Q38982455-1F57B085-242D-477E-B5B8-1C053D360233Q39284101-227B7B6F-BD8D-4687-BE06-891508C6D131
P2860
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The extent of genetic diversit ...... terns: a need for reappraisal.
@en
The extent of genetic diversit ...... terns: a need for reappraisal.
@nl
type
label
The extent of genetic diversit ...... terns: a need for reappraisal.
@en
The extent of genetic diversit ...... terns: a need for reappraisal.
@nl
prefLabel
The extent of genetic diversit ...... terns: a need for reappraisal.
@en
The extent of genetic diversit ...... terns: a need for reappraisal.
@nl
P2093
P2860
P1433
P1476
The extent of genetic diversit ...... terns: a need for reappraisal.
@en
P2093
Allan Hildesheim
Cindy M Chang
Kelly J Yu
Kishor Bhatia
P2860
P304
P356
10.1016/J.VIRUSRES.2009.07.005
P577
2009-07-23T00:00:00Z